Stock VM VOYAGEUR PHARMACEUTICALS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Voyageur Pharmaceuticals Ltd.

Equities

VM

CA92918C1014

Delayed Toronto S.E.
Other stock markets
 16:18:42 15/05/2024 BST 		5-day change 1st Jan Change
0.055 CAD 0.00% Intraday chart for Voyageur Pharmaceuticals Ltd. 0.00% -26.67%
04-26 Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended February 29, 2024 CI
03-26 Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended November 30, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended February 29, 2024
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended November 30, 2023
Voyageur Pharmaceuticals Ltd. Announces A Significant Advancement in Its Partnership with Rain Cage Carbon Inc
Voyageur Pharmaceuticals Ltd. and Applied Pharmaceutical Innovation Sign Master Services Agreement
Voyageur Pharmaceuticals Ltd. Announces the Formalization of A Pivotal Sales and Distribution Alliance
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023
Voyageur Pharmaceuticals Ltd. Announces Board Changes
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023
Voyageur Pharmaceuticals Ltd. Announces the Release of the White Paper
Voyageur Pharmaceuticals Ltd. Advances with Environmental Field Work At Frances Creek Project Site for Notice of Work & Quarry Permitting
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended February 28, 2023
Voyageur Pharmaceuticals Ltd. Completes Comparative Studies of Its SmoothX® Contrast Media Confirming Product Superiority
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended November 30, 2022
Voyageur Pharmaceuticals Ltd. Auditor Raises 'Going Concern' Doubt
Voyageur Pharmaceuticals Ltd. Announces Canadian Launch of Smoothx Barium Contrast Media & Financing
Voyageur Pharmaceuticals Ltd. Completes Medical Imaging CT Contrast Agent Production Testing and Begins Production Scale-Up of SmoothX
Voyageur Pharmaceuticals Ltd. Completes Design of Carbon Neutral Pharmaceutical Facility on Alberta
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022
Voyageur Pharmaceuticals’ MOU with Rain Cage Carbon to Develop Fullerene-Based Medical Contrast Agents from Carbon Capture of Hydrocarbon Exhaust Systems
Voyageur Pharmaceuticals Ltd Signs Memorandum of Understanding with Rain Cage Carbon Inc
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VM Stock
  4. News Voyageur Pharmaceuticals Ltd.
  5. Other languages